Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 months

International Urogynecology Journal

Volumn 20, Issue 4, 2009, Pages 381-385

  Rogers, Rebecca G ^a   Omotosho, Tola ^a   Bachmann, Gloria ^b   Sun, Franklin ^c   Morrow, Jon D ^c  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c PFIZER INC   (United States)

Author keywords

Overactive bladder; Patient reported outcomes; Urgency urinary incontinence; Urinary incontinence; Women

Indexed keywords

TOLTERODINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPEN STUDY; OVERACTIVE BLADDER; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SYMPTOMATOLOGY; TREATMENT DURATION; URGE INCONTINENCE; URINARY TRACT INFECTION; XEROSTOMIA;

EID: 62249118507     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-008-0782-9     Document Type: Article

References (19)

1. Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrebroeck P, Sand P (2006) Reviewing the ICS 2002 terminology report: The ongoing debate. Neurourol Urodyn 25:293
2. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein A (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327-336
3. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur Urol 50:1306-1315
4. Abrams P, Kellecher CJ, Kerr LA, Rogers RG (2000) Overactive bladder significantly affects quality of life. Am J Manag Care 6:S580-S590
5. Coyne KS, Margolis MK, Jumadilova Z, Bavendam T, Mueller E, Rogers R (2007) Overactive bladder and women's sexual health: What is the impact? J Sex Med 4:656-666
6. Van Kerrebroeck P, Kreder K, Jonas U et al (2001) Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder. Urology 57:414-421
7. Rogers R, Bachmann G, Jumadilova Z, Sun F, Morrow JD, Guan Z, Bavendam T (2008) Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women. Int J Urogynecol Pelvic Floor Dysfunct 19:1551-1557
8. Kreder K, Mayne C, Jonas U (2002) Long-term tolerability and efficacy and extended-release tolterodine in the treatment of overactive bladder. Eur Urol 41:588-595
9. Kelleher CJ, Kreder KJ, Pleil AM et al (2002) Long-term health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. Am J Manag Care 8:S616-S630
10. Coyne KS, Matza LS, Kopp Z et al (2006) The validation of the Patient Perception of Bladder Condition (PPBC): A single-item global measure for patients with overactive bladder. Eur Urol 49:1079-1086
11. Coyne K, Revicki D, Hunt T et al (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q. Qual Life Res 11:563-574
12. Rogers RG, Kammerer-Doak D, Villarreal A, Coates K, Qualls C (2001) A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse. Am J Obstet Gynecol 184:552-558
13. Symonds T, Boolell M, Quirk F (2005) Development of a questionnaire on sexual quality of life in women. J Sex Marital Ther 31:385-397
14. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370
15. Rogers RG, Kammerer-Doak D, Darrow A, Murray K, Olsen A, Barber M, Qualls C (2006) Does sexual function change after surgery for stress urinary incontinence and/or pelvic organ prolapse: A multi-center prospective study. Am J Obstet Gynecol Nov 195(5):e1-4
16. Baessler K, Stanton SL (2004) Does Burch colposuspension cure coital incontinence? Am J Obstet Gynecol 190:1030-1033
17. D'Souza AO, Smith MJ, Miller LA, Doyle J, Ariely R (2008) Persistence, adherence and switch rates among extended release overactive bladder medications in a regional managed care plan. J Manag Care Pharm 14(3):291-301
18. Basra RK, Wagg A, Chapple C, Cardozo L, Castro-Diaz D, Pons ME et al (2008) A review of adherence to drug therapy in patients with overactive bladder. BJU Int 102:774-779
19. Ouslander JG, Shih YT, Malone-Lee J, Luber K (2000) Overactive bladder: special considerations in the geriatric population. Am J Manag Care 6(11):S599-S606